Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.
Ji L, Du Y, Xu M, Zhou X, Mo Z, Ma J, Li J, Li Y, Lin J, Wang Y, Yang J, Song W, Jin H, Pang S, Liu H, Li P, Liu J, Yao M, Li W, Jiang X, Shen F, Geng H, Zhou H, Ran J, Lei M, Du Y, Ye S, Guan Q, Lv W, Tan H, Chen T, Yang J, Qin G, Li S, Chen L.
Ji L, et al. Among authors: li s, li y, li j, li w, li p.
Diabetologia. 2021 Aug;64(8):1900-1901. doi: 10.1007/s00125-021-05460-0.
Diabetologia. 2021.
PMID: 34037812
Free PMC article.
No abstract available.